High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases

Medicine

Volumn 90, Issue 2, 2011, Pages 89-98

  Dezern, Amy E ^a   Petri, Michelle ^b   Drachman, Daniel B ^c   Kerr, Doug ^f   Hammond, Edward R ^c   Kowalski, Jeanne ^d   Tsai, Hua Ling ^d   Loeb, David M ^a   Anhalt, Grant ^e   Wigley, Fredrick ^b   Jones, Richard J ^a   Brodsky, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Rheumatology   (United States)

^c Division of Neurology   (United States)

^d Division of Oncology Biostatistics   (United States)

^e Division of Dermatology   (United States)

^f BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA; NARCOTIC AGENT; NORFLOXACIN; ONDANSETRON; PREDNISONE; SULFAMETHOXAZOLE; THYMOCYTE ANTIBODY; TRIMETHOPRIM; VALACICLOVIR;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ALOPECIA; ANTIBIOTIC PROPHYLAXIS; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENTEROPATHY; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BLADDER IRRIGATION; BONE MARROW DISEASE; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ASSESSMENT; COLLAGENOUS GASTROENTERITIS; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE CONCENTRATE; ETHNICITY; EVALUATION AND FOLLOW UP; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL DISEASE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NAUSEA; NEUTROPHIL COUNT; OVERALL SURVIVAL; PANCYTOPENIA; PEMPHIGUS VULGARIS; PNEUMOCYSTOSIS; PNEUMONIA; POEMS SYNDROME; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PURE RED CELL ANEMIA; RELAPSE; REMISSION; RETICULOCYTE COUNT; SCLERODERMA; SEPSIS; SUICIDE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 79952438500     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e318210e685     Document Type: Article

References (48)

1. Audino AN, Blatt J, Carcamo B, Castaneda V, Dinndorf P, Wang WC, Whitlock JA, Hord JD. High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children. Pediatr Blood Cancer. 2010;54:269-272.
2. Baran DT, Griner PF, Klemperer MR. Recovery from aplastic anemia after treatment with cyclophosphamide. N Engl J Med. 1976;295:1522-1523. (Pubitemid 8014699)
3. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630-640.
4. Brannagan TH III, Pradhan A, Heiman-Patterson T, Winkelman AC, Styler MJ, Topolsky DL, Crilley PA, Schwartzman RJ, Brodsky I, Gladstone DE. High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology. 2002;58:1856-1858. (Pubitemid 34663593)
5. Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith BD, Matsui WH, Goodman SN, Ambinder RF, Jones RJ. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up. Blood. 2010;115:2136-2141.
6. Brodsky RA, Jones RJ. Aplastic anaemia. Lancet. 2005;365:1647-1656. (Pubitemid 40703909)
7. Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, Dang CV, Brodsky I, Jones RJ. Immunoablative high-dose cyclophosphamide without stem cell rescue for refractory severe autoimmune disease. Ann Intern Med. 1998;129:1031-1035. (Pubitemid 29005827)
8. Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide. Blood. 1996;87:491-494. (Pubitemid 26030304)
9. Brodsky RA, Smith BD. Bone marrow transplantation for autoimmune diseases. Curr Opin Oncol. 1999;11:83-86. (Pubitemid 29151465)
10. Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Loh Y, Territo M, Cohen BA, Craig RM, Varga J, Barr WG. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 2006;54:3750-3760. (Pubitemid 44955875)
11. Burt RK, Testori A, Craig R, Cohen B, Suffit R, Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned? J Autoimmun. 2008;30:116-120.
12. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa BM, Takahashi M, Jovanovic B, Oyama Y. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA. 2006;295:527-535. (Pubitemid 43200347)
13. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999;122:871-882. (Pubitemid 29219261)
14. Doney K, Storb R, Buckner CD, McGuffin R,Witherspoon R, Deeg HJ, Appelbaum FR, Sullivan KM, Thomas ED. Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol. 1987;15:239-242. (Pubitemid 17066433)
15. Drachman DB, Adams RN, Hu R, Jones RJ, Brodsky RA. Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis. Ann N Y Acad Sci. 2008;1132:305-314. (Pubitemid 351841373)
16. Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 2009;6:638-647.
17. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van LJ, Ouyang J, Kozak T, Moore J, Kotter I, Chesnel V, Marmont A, Gratwohl A, Saccardi R. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica. 2010;95:284-292. [Epub 2009 Sep 22.]
18. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101:1236-1242. (Pubitemid 36182490)
19. Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis. Arch Neurol. 2006;63:1388-1393. (Pubitemid 44547549)
20. Gmur J, von Felten A, Rhyner K, Frick PG. Autologous hematologic recovery from aplastic anemia following high dose cyclophosphamide and HLA-matched allogeneic bone marrow transplantation. Acta Haematol. 1979;62:20-24. (Pubitemid 9254885)
21. Hilton J. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res. 1984;44:5156-5160. (Pubitemid 15204481)
22. Jaime-Perez JC, Gonzalez-Llano O, Gomez-Almaguer D. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children. Am J Hematol. 2001;66:71.
23. Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J. Assessment of aldehyde dehydrogenase in viable cells. Blood. 1995;85:2742-2746.
24. Kastan MB, Schlaffer E, Russo JE, Colvin OM, Civin CI, Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood. 1990;75: 1947-1950.
25. Killick SB, Win N, Marsh JC, Kaye T, Yandle A, Humphries C, Knowles SM, Gordon-Smith EC. Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia. Br J Haematol. 1997;97:677-684. (Pubitemid 27261641)
26. Krishnan C, Kaplin AI, Brodsky RA, Drachman DB, Jones RJ, Pham DL, Richert ND, Pardo CA, Yousem DM, Hammond E, Quigg M, Trecker C, McArthur JC, Nath A, Greenberg BM, Calabresi PA, Kerr DA. Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. Arch Neurol. 2008;65:1044-1051.
27. Li Z, Yin S, Xie S, Ma L, Nie D, Xsu L. Treatment of severe aplastic anemia using high-dose cyclophosphamide alone in China. Haematologica. 2000;85:E06.
28. Mathe G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M, Hayat M, Schlumberger JR, Jasmin Cl. Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J. 1970;2:131-136.
29. McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R, Mayes MD, McDonagh KT, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Ryan K, Sunderhaus J, Russell K, Rambharose J, Storb R, Furst DE. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood. 2002;100:1602-1610. (Pubitemid 34925135)
30. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood. 2002;100:704-706. (Pubitemid 34761141)
31. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, Sasaki H, Okamura J, Sugita K, Kigasawa H, Kiriyama Y, Akatsuka J, Tsukimoto I. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009-1013. (Pubitemid 27314134)
32. Oliva-Hemker MM, Loeb DM, Abraham SC, Lederman HM. Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. J Pediatr Gastroenterol Nutr. 2003;36:639-643. (Pubitemid 39274592)
33. Passweg JR, Perez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socie G, Zhang MJ, Bredeson C. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant. 2006;37:641-649.
34. Passweg JR, Socie G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang M-J, Horowitz MM, Bortin MM. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood. 1997;90:858-864. (Pubitemid 27299127)
35. Petri M, Brodsky RA, Jones RJ, Gladstone D, Fillius M, Magder LS. High dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial. Arthritis Rheum. 2010;62:1487-1493.
36. Petri M, Jones RJ, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum. 2003;48:166-173. (Pubitemid 36091660)
37. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289:1130-1135. (Pubitemid 37430327)
38. Santos GW, Sensenbrenner LL, Burke PJ, Mullins GM, Bias WB, Tutschka PJ, Slavin RE. The use of cyclophosphamide for clinical marrow transplantation. Transplant Proc. 1972;4:559-564.
39. Sensenbrenner LL, Steele AA, Santos GW. Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: report of a case with diffusion chamber studies. Exp Hematol. 1977;5:51-58. (Pubitemid 8012454)
40. Sladek NE, Kollander R, Sreerama L, Kiang DT. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother Pharmacol. 2002;49:309-321. (Pubitemid 34253270)
41. Storb R, Blume KG, O'Donnell MR, Chauncey T, Forman SJ, Deeg HJ, Hu WW, Appelbaum FR, Doney K, Flowers ME, Sanders J, Leisenring W. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant. 2001;7:39-44. (Pubitemid 32229501)
42. Tehlirian CV, Hummers LK, White B, Brodsky RA, Wigley FM. High-dose cyclophosphamide without stem cell rescue in scleroderma. Ann Rheum Dis. 2008;67:775-781. (Pubitemid 351829377)
43. Thomas ED, Storb R, Fefer A, Slichter SJ, Bryant JI, Buckner CD, Neiman PE, Clift RA, Funk DD, Lerner KE. Aplastic anaemia treated by marrow transplantation. Lancet. 1972;1:284-289.
44. Thomas ED, Storb R, Giblett ER, Longpre B, Weiden PL, Fefer A, Witherspoon R, Clift RA, Buckner CD. Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol. 1976;4:97-102.
45. Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, Barrett AJ, Walsh TJ, Rosenfeld SJ, Young NS. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet. 2000;356:1554-1559.
46. Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol. 2005;141:1-9. (Pubitemid 40904634)
47. Viollier R, Passweg J, Gregor M, Favre G, Kuhne T, Nissen C, Gratwohl A, Tichelli A. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Ann Hematol. 2005;84:47-55. (Pubitemid 39618780)
48. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-2519.